Most-Read Print Managed Healthcare Executive® Articles of 2021
Many of the most-read articles from the print issues of Managed Healthcare Executive® focused on the cost of therapies.
The Price Tags on the COVID-19 Vaccines
Governments are the only buyers so far, and the amounts they are paying varies.
The Pandemic Pause: When Cancer Care Was Put on Hold
Screening and some care have been canceled or deferred. Will more illness and deaths result?
Generic Drug Price Tags: Too High. And Too Low. Competition Can Help Create an In-Between.
Low prices and some gaming of regulations can drive out competitors and create monopolies that allow generic makers to jack up their prices. Experience has shown that it often takes multiple generics to achieve the promised-for downward pressure on prices.
The Rise in Formulary Exclusions
PBMs say exclusions are important for negotiating lower prices on behalf of health plans and members. Some payer and provider groups say they interfere with patient access to medicines.
How ‘White Bagging’ Affects Patients, Physicians and 340B Funding
Having specialty pharmacies fill prescriptions may lower costs, but critics of the practice see safety issues and other drawbacks.
Today, the clade 2b outbreak has reached alarming proportions, with over 94,000 confirmed cases reported across 117 countries, including significant numbers in the U.S. and Brazil, and up to 103 deaths. The virus has been found to affect younger men who have sex with men, who are linked to high rates of HIV co-infection.
Read More
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
In our latest "Meet the Board" podcast episode, Managed Healthcare Executive Editors caught up with editorial advisory board member, Eric Hunter, CEO of CareOregon, to discuss a number of topics, one including the merger that never closed with SCAN Health Plan due to local opposition from Oregonians.
Listen
